Doxazosin Mesylate
Doxazosin Mesylate (S1324-GRP)
Products
Description
Doxazosin, a quinazoline-derivative, selectively antagonizes postsynaptic α1-adrenergic receptors, used in the treatment of high blood pressure and urinary retention associated with benign prostatic hyperplasia.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S1324 |
| Target | Adrenergic Receptor |